Ovuloc (Desogestrel and Ethinyl Estradiol Tablets)

1. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) © All Contraceptives

2. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) © All Contraceptives

3. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Ovuloc (Desogestrel and Ethinyl Estradiol Tablets) is a combined oral contraceptive preparation used to prevent pregnancy. It is a birth control pill that contains two types of hormones, Desogestrel and Ethinyl Estradiol, and when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization (pregnancy) is prevented. Besides preventing pregnancy, birth control pills may make your periods more regular, decrease blood loss and painful periods, decrease your risk of ovarian cysts, and also treat acne. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia). © All Contraceptives

4. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) In addition, some serious disorders have been reported to occur less frequently in users of Combined Pills. These are: benign breast disease, ovarian cysts, pelvic infections (pelvic inflammatory disease), ectopic pregnancy (pregnancy in which the embryo implants outside of the womb) and cancer of the endometrium (lining of the womb) and ovaries. When taken according to the recommended dosage scheme Ovuloc contraceptive tablets suppresses the hypophyseal gonadal function and thereby ovulation. © All Contraceptives

5. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Active Ingredients The active pharmaceutical ingredients contained in Ovuloc Tablets are Desogestrel and Ethinyl Estradiol. Each pack of Ovuloc tablets contains 21 active tablets containing 150 mcg of Desogestrel and 30 mcg of Ethinyl Estradiol. © All Contraceptives

6. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Chemical Structure - Desogestrel © All Contraceptives

7. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Chemical Structure - Ethinyl Estradiol © All Contraceptives

8. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Ovuloc Tablets Ovuloc Tablets are manufactured by Serum Institute of India Private Ltd. (In collaboration with Maneesh Pharmaceutical Ltd.) (Website: https://www.seruminstitute.com/) URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

9. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Uses of Ovuloc Tablets Ovuloc (Desogestrel and Ethinyl Estradiol combination tablets) for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. It is a birth control pill that contains two types of hormones, Desogestrel and Ethinyl Estradiol, and when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization (pregnancy) is prevented. Besides preventing pregnancy, birth control pills may make your periods more regular, decrease blood loss and painful periods, decrease your risk of ovarian cysts, and also treat acne. Using this medication does not protect you or your partner against sexually transmitted diseases. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

10. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Recommended Dosage The dosage of Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) is given below: To achieve Day 1 Start: The dosage of Ovuloc for the initial cycle of therapy is one “active” tablet administered daily from the 1st day through the 21st day of the menstrual cycle, counting the first day of menstrual flow as “Day 1”. Tablets are taken without interruption as follows: One “active” tablet daily for 21 days, followed by 7 tablet free days. After which new course is started and a “active” tablet is taken the next day. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

11. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Recommended Dosage The dosage of Ovuloc tablets (Desogestrel and Ethinyl Estradiol Tablets) is given below: Sunday Start: When taking Ovuloc, the first “active” tablet should be taken on the first Sunday after menstruation begins. If the period begins on Sunday, the first “active” tablet is taken on that day. If switching directly from another oral contraceptive, the first “active” tablet should be taken on the first Sunday after the last ACTIVE tablet of the previous product. Tablets are taken without interruption as follows: One “active” tablet daily for 21 days, followed by 7 tablet free days. When initiating a Sunday start regimen, another method of contraception should be used until after the first 7 consecutive days of administration. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

12. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Contraindications Ovuloc tablets are contraindicated in patients with a hypersensitivity to Desogestrel, Ethinyl Estradiol or any other component of this medication. The other contraindications are: Thrombophlebitis or thromboembolic disorders A past history of deep vein thrombophlebitis or thromboembolic disorders Cerebral vascular or coronary artery disease History of migraine with focal neurological symptoms Diabetes mellitus with vascular involvement. Presence of a severe or multiple risk factor(s) for venous or arterial thrombosis Pancreatitis or a history thereof if associated with severe hypertriglyceridaemia. © All Contraceptives

13. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Contraindications The other contraindications of Ovuloc tablets are: Current diagnosis of, or history of, breast cancer, which may be hormone-sensitive Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia Undiagnosed abnormal genital bleeding Cholestatic jaundice of pregnancy or jaundice with prior pill use Presence or history of severe hepatic disease as long as liver function values have not returned to normal. Hepatic adenomas or carcinomas Undiagnosed vaginal bleeding. Known or suspected pregnancy Are receiving Hepatitis C drug combinations containing Ombitasvir / Paritaprevir/ Ritonavir, with or without dasabuvir, due to the potential for ALT elevations. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

14. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Storage Instructions Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) have to be stored at controlled room temperature i.e. from 20°C to 25°C (68°F to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Keep this as well as all other medicines away from children and pets. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

15. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Warnings Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. Thromboembolic Disorder and Other Vascular Problems: An increased risk of thromboembolic and thrombotic disease associated with the use of oral contraceptives is well established. An increased risk of myocardial infarction has been attributed to oral contraceptive use. This risk is primarily in smokers or women with other underlying risk factors for coronary artery disease such as hypertension, hypercholesterolemia, morbid obesity, and diabetes. The relative risk of heart attack for current oral contraceptive users has been estimated to be two to six. The risk is very low in women under the age of 30. Oral contraceptives have been shown to increase both the relative and attributable risks of cerebrovascular events (thrombotic and hemorrhagic strokes), although, in general, the risk is greatest among older (greater than 35 years), hypertensive women who also smoke. A positive association has been observed between the amount of estrogen and progestogen in oral contraceptives and the risk of vascular disease. A decline in serum high density lipoproteins (HDL) has been reported with many progestational agents. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

16. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Warnings There are two studies which have shown persistence of risk of vascular disease for ever-users of oral contraceptives. In a study in the United States, the risk of developing myocardial infarction after discontinuing oral contraceptives persists for at least 9 years for women 40 to 49 years old who had used oral contraceptives for five or more years, but this increased risk was not demonstrated in other age groups. Estimates of Mortality from Contraceptive Use: The study concluded that with the exception of oral contraceptive users 35 and older who smoke and 40 and older who do not smoke, mortality associated with all methods of birth control is low and below that associated with childbirth. Malignant Neoplasms: Breast Cancer: Ovuloc (Desogestrel and Ethinyl Estradiol combination tablets) is contraindicated in females who currently have or have had breast cancer because breast cancer may be hormonally sensitive. Cervical Cancer: Some studies suggest that oral contraceptive use has been associated with an increase in the risk of cervical intraepithelial neoplasia in some populations of women. Hepatic Neoplasia: Benign hepatic adenomas are associated with oral contraceptive use, although the incidence of benign tumors is rare in the United States. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

17. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Warnings Risk of Liver Enzyme Elevations with Concomitant Hepatitis C Treatment: During clinical trials with the Hepatitis C combination drug regimen that contains Ombitasvir/ Paritaprevir/ Ritonavir, with or without Dasabuvir, ALT elevations greater than 5 times the upper limit of normal (ULN), including some cases greater than 20 times the ULN, were significantly more frequent in women using ethinyl Estradiol-containing medications such as COCs. Ocular Lesions: There have been clinical case reports of retinal thrombosis associated with the use of oral contraceptives. Oral contraceptives should be discontinued if there is unexplained partial or complete loss of vision; onset of proptosis or diplopia; papilledema; or retinal vascular lesions. Appropriate diagnostic and therapeutic measures should be undertaken immediately. Oral Contraceptive Use Before or During Early Pregnancy: Extensive epidemiological studies have revealed no increased risk of birth defects in women who have used oral contraceptives prior to pregnancy. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

18. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Warnings Gallbladder Disease: Earlier studies have reported an increased lifetime relative risk of gallbladder surgery in users of oral contraceptives and estrogens. More recent studies, however, have shown that the relative risk of developing gallbladder disease among oral contraceptive users may be minimal. Carbohydrate and Lipid Metabolic Effects: Oral contraceptives have been shown to cause a decrease in glucose tolerance in a significant percentage of users. This effect has been shown to be directly related to estrogen dose. Elevated Blood Pressure: Women with significant hypertension should not be started on hormonal contraception. An increase in blood pressure has been reported in women taking oral contraceptives and this increase is more likely in older oral contraceptive users and with extended duration of use. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

19. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Warnings Headache: The onset or exacerbation of migraine or development of headache with a new pattern which is recurrent, persistent or severe requires discontinuation of oral contraceptives and evaluation of the cause. Bleeding Irregularities: Breakthrough bleeding and spotting are sometimes encountered in patients on oral contraceptives, especially during the first three months of use. Non-hormonal causes should be considered and adequate diagnostic measures taken to rule out malignancy or pregnancy in the event of breakthrough bleeding, as in the case of any abnormal vaginal bleeding. Ectopic Pregnancy: Ectopic as well as intrauterine pregnancy may occur in contraceptive failures. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

20. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Side Effects The common possible side effects (occurring in more than one per 100 users) reported in patients treated with Ovuloc tablets are : Depressed mood, mood changes, Headache, Nausea, abdominal pain, Breast pain, breast tenderness, Increase in body weight. The uncommon side effects (occurring in more than one per 1000 users but not more than one per 100 users): Fluid retention, Decreased sexual drive, Migraine, Vomiting, diarrhoea Rash, hives, Breast enlargement. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

21. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Side Effects Stop taking Ovuloc and tell your doctor immediately, or go to accident and emergency at your nearest hospital, if you notice signs of any of the following: Thrombosis, An unusual cough, Severe pain in the chest which may reach the left arm, Breathlessness, Any unusual, severe, or prolonged headache or migraine attack, Partial or complete loss of vision, or double vision, Slurring or speech disability, Sudden changes to your hearing, sense of smell, or taste; Dizziness or fainting; Weakness or numbness in any part of your body; Severe pain in your abdomen; Severe pain or swelling in either of your legs; Liver disease including liver cancer (jaundice or a yellowing of the eyes or skin). URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

22. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Ovuloc Tablets Overdose Symptoms of overdose may include nausea, vomiting or vaginal bleeding. Available information from cases of accidental ingestion of oral contraceptives by children indicates no serious effects. In case of overdose or accidental ingestion by children, the physician should observe the patient closely, although generally no treatment is required. Gastric lavage may be utilized if considered necessary. Overdosage may cause nausea and vomiting and withdrawal bleeding may occur in females. There are no antidotes and treatment should be symptomatic. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

23. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) Ovuloc Tablets During Pregnancy Ovuloc (Desogestrel and Ethinyl Estradiol Tablets) has been classified by the US FDA as Pregnancy Category X. Oral contraceptives should not be taken by pregnant women. However, if conception accidentally occurs while taking the pill, there is no conclusive evidence that the estrogen and progestin contained in the oral contraceptive will damage the developing child. The administration of oral contraceptives to induce withdrawal bleeding should not be used as a test for pregnancy. Oral contraceptives should not be used during pregnancy to treat threatened or habitual abortion. It is recommended that for any patient who has missed two consecutive periods, pregnancy should be ruled out. URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives

24. Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) For more details on Ovuloc Tablets click here Ovuloc Tablets (Desogestrel and Ethinyl Estradiol Tablets) by Serum Institute of India Private Ltd. (In collaboration with Maneesh Pharmaceutical Ltd.) URL: https://www.allcontraceptives.com/ovuloc-tablets.html © All Contraceptives